Navigation Links
EntreMed Receives Nasdaq Deficiency Notice
Date:4/4/2008

ROCKVILLE, Md., April 4, 2008 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that on April 4, 2008, it received a Deficiency Notice from the Listing Qualifications Department of the NASDAQ Stock Market, LLC. The notice, in accordance with NASDAQ Marketplace Rule 4450(a)(5) "Minimum Bid Price Requirement," stated that the Company's common stock failed to close above the minimum closing bid price of $1.00 per share for 30 consecutive business days. This notification has no immediate effect on the NASDAQ listing or trading of the Company's common stock.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

In accordance with Marketplace Rule 4450(e)(2), EntreMed will have 180 calendar days, or until October 1, 2008, to regain compliance with the minimum $1.00 share bid price requirement. To regain compliance with the minimum bid price requirement, EntreMed's common stock must meet or exceed the $1.00 share price for 10 consecutive business days.

EntreMed intends to actively monitor the bid price for its common stock between now and October 1, 2008, and will consider available options, including a reverse stock split. In order to make available the option of a reverse stock split, EntreMed intends to submit a reverse stock split proposal to its stockholders at the Company's Annual Meeting of Stockholders on June 5, 2008. If a reverse stock split is approved by our stockholders and implemented, it would not only allow the Company to maintain its listing on the NASDAQ Global Market, but facil
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. EntreMed to Present at BioCentury Future Leaders in the Biotech Industry Conference
2. EntreMed Announces 2008 Corporate and Clinical Program Priorities
3. EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results
4. EntreMed to Present at BIO CEO and Investor Conference
5. EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study
6. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
7. EntreMed Appoints Senior Vice President of Research and Development
8. EntreMed to Present at ThinkEquity Partners 5th Annual Growth Conference
9. Memory Pharmaceuticals Receives Nasdaq Notification
10. Proteolixs Carfilzomib Receives Orphan Drug Designation for Treatment of Multiple Myeloma
11. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., ST.LOUIS,Nov.24/PRNewswire-FirstCall/--Sigma-...ttheNASDAQOMXconferenceonTuesday,December1stat1:45...tenvialiveaudiobroadcastovertheInternetavailableat...Userscanclickthe"Webcast"icontoaccessthisfile. ,...ifeScienceandHighTechnologycompany.Itschemicalandb...
(Date:11/24/2009)..., SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/-...ompanyfocusedondevelopingandcommercializingnovelpa...onno,PresidentandChiefExecutiveOfficer,isscheduled...erence,tobeheldDecember1-2,2009atTheNewYorkPalaceH...higlieri,ChiefFinancialOfficer,willbeavailabletore...
(Date:11/24/2009)..., ,Primaryefficacyendpointhasbeenmetforpatientsw..., QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEter...),aglobalbiopharmaceuticalcompanyfocusedonendocrin...datafromaPhase2studywithitstargetedcytotoxicpeptid...advancedorrecurrentendometrialcancer.Inapersonaliz...
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCal...dthatRandyScott,GenomicHealth,sExecutiveChairman,w...ferenceinNewYorkCityonTuesday,December1,2009at10:0...vedwebcastofthepresentation,visittheInvestorRelati...or.genomichealth.com .Pleaseconnecttothewebsiteatl...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...euticals,Inc. (Nasdaq: CADX ), a biopharmaceutica...ommercializing proprietary product candidates prin...ounced that it completed its,previously announced ...llion shares of common stock at a price of $5.34 p...The proceeds from the offering will enable us to c...
...eutics, Inc., a,privately held ophthalmic-focused ... has entered into an exclusive licensing agreement...worldwide rights to develop and,market topical oph...oprietary anti- inflammatory agent norketotifen., ...220/CLW064LOGO ), "This agreement represents yet...
...ntures, specializing,in seed and early-stage inves...today announced the expansion of the firm,s invest..., PhD, as Venture Partner. 5AM Ventures,also annou...ociates, Kevin,M. Forrest, PhD, and R. Andrew McMi... have been with the 5AM team since early 2005. Car...
Other Biology Technology:Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering 2Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering 3Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases 25AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal 25AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal 3
(Date:11/26/2009)...pressive antlers, red deer have been caught in the...lers are much more than decorative. They are letha... John Currey, from The University of York, UK, has...ne for over half a century and has become fascinat...a long-standing collaboration with Tomas Landete-C...
(Date:11/26/2009)...November 2009 What are the bare essentials of lif...ce a cell that can survive on its own? Can we desc...nd how an entire organism functions as a system? T...s in a partnership between the European Molecular ...and the Centre de Regulacio Genmica (CRG) in Barce...
(Date:11/25/2009)...ia don,t have easy lives. In addition to mammalian...atural enemies called bacteriophages, viruses that..., Still, bacteria and another class of microorga...environments such as deep-sea volcanic vents) mana... a built-in defense system that helps protect them...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Male seahorses like big mates 9136 1Male seahorses like big mates 9136 2Hormone clue to root growth 9134 1Hormone clue to root growth 9134 2Journal of Vascular and Interventional Radiology 3A New patient radiation safety guidelines 9132 1Journal of Vascular and Interventional Radiology 3A New patient radiation safety guidelines 9132 2Journal of Vascular and Interventional Radiology 3A New patient radiation safety guidelines 9132 3
...veling migratory moths may hitch a ride on the win...urrent Biology, a Cell Press publication, confirm...us report also in Current Biology offered the fi...icated internal compass, sailing on favorable wind...in a matter of days. Now, the research team that b...
...I When it comes to embryo formation in the lowly ...eads to enhanced developmental precision, accordin...from Cincinnati Children,s Hospital Medical Center...roductive biology may seem insignificant, one day ...cause the study provides new information about how...
... Calif.-- The transportation of antibodies from a ...opment of that child,s nascent immune system. Thos...nta before birth or via breast milk after birth, h...nd may influence the later occurrence of autoimmun...ia Institute of Technology (Caltech) have revealed...
Other Biology News:Migratory moths may hitch their rides, but they're anything but drifters 2Scientists trace molecular origin of proportional development 2Scientists trace molecular origin of proportional development 3Caltech biologists spy on the secret inner life of a cell 2Caltech biologists spy on the secret inner life of a cell 3
...0 contains 400 unique human proteins on a 1x3 inch...a cross section of all cellular proteins, are arra...itional control proteins and a specific chip layou...NIchip protein microarrays are high-density protei...
...0 contains 400 unique human proteins on a 1x3 inch...all extracellular proteins (EP) according to Gene ...ate for high-quality results. Additional control p...validity and reproducibility., UNIchip protein mic...
...s are E.Coli glycerol stocks contained in standard...cDNA clones with approximately 5,000 clones per pl... plate well, the corresponding subplate is screene...ve well(s). Cells from a positive well are then pl...
...ed Reticulocyte Lysate Systems(a,b,c,d) offer rese...nslations: a single-tube, coupled transcription/tr...implify the process and reduce the time required t...bbit reticulocyte lysate translations (1) commonly...
Biology Products: